Package 10122-620-10

{"route": ["INTRAVENOUS"], "spl_id": "8c5e6180-c346-48e7-818d-471089de4ee7", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143"], "unii": ["6AQ1Y404U7"], "rxcui": ["1656056", "1656061"], "spl_set_id": ["88b434fa-8891-4fd5-9d86-7ea64667c08f"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]"], "manufacturer_name": ["Chiesi USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-USE in 1 CARTON (10122-620-10)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (10122-620-01)", "package_ndc": "10122-620-10", "marketing_start_date": "20150708"}], "brand_name": "KENGREAL", "product_id": "10122-620_8c5e6180-c346-48e7-818d-471089de4ee7", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Decreased Platelet Aggregation [PE]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "10122-620", "generic_name": "cangrelor", "labeler_name": "Chiesi USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "KENGREAL", "active_ingredients": [{"name": "CANGRELOR", "strength": "50 mg/1"}], "application_number": "NDA204958", "marketing_category": "NDA", "marketing_start_date": "20150708", "listing_expiration_date": "20261231"}